More than 60% of participant dietary consumption plans showed no significant difference between omalizumab and multi-food oral immunotherapy success rates after 12 months MILWAUKEE, Feb. 22, 2026...

Increased rates of NICU admission, preterm birth, eclampsia and additional adverse outcomes were shown for mothers with this allergy label and their infants MILWAUKEE, Feb. 21, 2026 /PRNewswire/...

Revision Skincare®, a professional-grade skincare brand recognized for its clinical research and evidence‑based results, today announced that DEJ Daily Boosting Serum™ has been named Winner...

PBF Energy Inc. (NYSE:PBF) today announced that members of its management team will participate in the Scotiabank Global Energy Conference on February 25, 2026; the Raymond James Institutional...

Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James 47th Annual Institutional Investors...